数字农科院2.0

Metabolite-mediated crosstalk: unraveling the interactions between gut microbiota and host in fatty liver hemorrhagic syndrome of laying hens

文献类型： 外文期刊

作者： Shaobo Zhang;Xinghua Zhao;Xin He;Wanyu Shi;Ning Ma

作者机构：

关键词： Fatty liver hemorrhagic syndrome;Gut microbiota;Gut-liver axis;Metabolites;Non-alcoholic fatty liver disease

期刊名称： Journal of Animal Science and Biotechnology

ISSN： 1674-9782

年卷期： 2026 年 17 卷 1 期

页码：

收录情况： SCIE（2025版） ; ; CSCD（2025-2026年度） ; ; 科技核心（2024版） ; ; 农林核心（2024版）

摘要： Fatty liver hemorrhagic syndrome (FLHS) in laying hens is a metabolic disorder characterized by excessive hepatic lipid accumulation, inflammation, and hemorrhage, bearing pathological similarities to human non-alcoholic fatty liver disease. With the rise of intensive poultry farming, the incidence of FLHS has markedly increased, resulting in significant economic losses in the poultry industry. The gut microbiota plays a crucial role in host digestion, metabolism, and immune regulation, particularly in liver diseases. Gut microbiota and its metabolites influence liver health via the gut-liver axis. This review aims to explore metabolite-mediated interactions between the laying hens and the gut microbiota, elucidating their role in the pathogenesis of FLHS. Host-derived metabolites, such as lipids, bile acids, amino acids, and carbohydrates, regulate the structure and function of the gut microbiota through the gut-liver axis, playing a role in FLHS progression. Concurrently, microbial metabolites, including short-chain fatty acids, bile acids, and amino acid derivatives, influence hepatic lipid metabolism, inflammation, and oxidative stress, driving the development of FLHS. Key microbes, such as Bacteroides, Lactobacillus, and Akkermansia muciniphila, are considered potential therapeutic targets due to their involvement in metabolite production. By integrating multi-omics data and mechanistic studies, this review highlights the central role of host–gut microbiota communication in FLHS and provides a theoretical basis and research direction for the development of microbiota-based intervention strategies.

分类号：

  • 相关文献

[1]Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut-liver axis. Han, Hui,Jiang, Yi,Wang, Mengyu,Melaku, Mebratu,Liu, Lei,Zhao, Yong,Everaert, Nadia,Yi, Bao,Zhang, Hongfu. 2021

[2]Effects of inactivated Bacillus sp. DU-106 on high-fat diet-induced obesity and the gut-liver axis. Li, Yanli,Zhao, Wenjun,Jiang, Bingyan,Huang, Xiao-Chun,Liu, Jie,Huang, Junyuan,Hu, Bang,Liu, Yong-Xin,Du, Bing,Li, Pan. 2025

[3]Nettle (Urtica cannabina L.) polysaccharides as a novel dietary supplement: enhancing systemic antioxidant status via modulation of the gut-liver axis. Zhang, Jize,Zhang, Qian,Zhang, Xiaoqing,Qiao, Jiang,Wang, Jingwei,Gao, Yang,Dong, Ping. 2025

[4]From gut microbiota to host appetite: gut microbiota-derived metabolites as key regulators. Hui Han,Bao Yi,Ruqing Zhong,Mengyu Wang,Shunfen Zhang,Jie Ma,Yulong Yin,Jie Yin,Liang Chen,Hongfu Zhang. 2021

[5]The ratios of dietary non-fibrous carbohydrate (NFC) to neutral detergent fiber (NDF) influence intestinal immunity of rabbits by regulating gut microbiota composition and metabolites. Li, Shuo,Liu, Tingting,Wang, Kun,Li, Chong,Wu, Fengyang,Yang, Xinyu,Zhao, Man,Chen, Baojiang,Chen, Xiang. 2023

[6]Chenodeoxycholic Acid Improves Embryo Implantation and Metabolic Health through Modulating Gut Microbiota–Host Metabolites Interaction during Early Pregnancy. Chen M.,Zhao Y.,Ji H.,Li L.,Liu H.,Wang S.,Zhang D.,Yin J.,Wang J.,Zhang X.. 2024

[7]Different microbiota modulation and metabolites generation of five dietary glycans during in vitro gut fermentation are determined by their monosaccharide profiles. Yuanyuan Zhao,Yubin Wang,Qiancheng Ma,Dan Wang,Qianqian Jiang,Pan Wang,Zhiwen Ge,Junjuan Wang,Peiyou Qin,Xiaoyan Zhao. 2024

[8]Enrichment efficiency of lutein in eggs and its function in improving fatty liver hemorrhagic syndrome in aged laying hens. Dansou D.M.,Chen H.,Yu Y.,Yang Y.,Tchana I.N.,Zhao L.,Tang C.,Zhao Q.,Qin Y.,Zhang J.. 2024

[9]Quantitative lipidomics reveals the changes of lipids and antioxidant capacity in egg yolk from laying hens with fatty liver hemorrhagic syndrome. Honglei Guo,Xinbo Zhang,Manhua You,Youming Shen,Shaobo Zhang,Jiefeng Li,Xin He,Xinghua Zhao,Ning Ma. 2024

[10]Effects of Different Green Teas on Obesity and Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice. Zhou, Dan-Dan,Mao, Qian-Qian,Li, Bang-Yan,Saimaiti, Adila,Huang, Si-Yu,Xiong, Ruo-Gu,Shang, Ao,Luo, Min,Li, Hang-Yu,Gan, Ren-You,Li, Hua-Bin,Li, Sha. 2022

[11]Plant sterol ester of α-linolenic acid improved non-alcoholic fatty liver disease by attenuating endoplasmic reticulum stress-triggered apoptosis via activation of the AMPK. Hao Han,Tingli Xue,Jie Li,Yan Guo,Xiaoyu Li,Linqi Wang,Liyuan Pei,Mingming Zheng. 2022

[12]Mitochondrial mechanism of florfenicol-induced nonalcoholic fatty liver disease in zebrafish using multi-omics technology. Lin Zhang,Yang Du,Yameng Li,Tiancai Wang,Yecan Pan,Xiaofeng Xue,Xiyan Mu,Jing Qiu,Yongzhong Qian. 2025

[13]Accelerated Biological Aging, Genetic Susceptibility, and Non-Alcoholic Fatty Liver Disease: Two Prospective Cohort Studies. Zhao, Ying,Wang, Yu,Chen, Li,Chen, Huimin,Tang, Yuhan,He, Yuefeng,Yao, Ping. 2025

[14]Baicalin Alleviates Short-Term Lincomycin-Induced Intestinal and Liver Injury and Inflammation in Infant Mice. Zhang, Shunfen,Zhong, Ruqing,Tang, Shanlong,Han, Hui,Chen, Liang,Zhang, Hongfu. 2022

[15]Dietary fiber-derived short-chain fatty acids: A potential therapeutic target to alleviate obesity-related nonalcoholic fatty liver disease. Shumin Zhang,Jingwen Zhao,Fei Xie,Hengxun He,Lee J. Johnston,Xiaofeng Dai,Chaodong Wu,Xi Ma. 2021

[16]Phlorizin Alleviates Inflammation Caused by Deoxynivalenol by Regulating the Gut Microbiome and Inhibiting the TLR4/MyD88/NF-κB Signaling Pathway in Mice. Zhao T.,Jin J.,Huangfu B.,He X.,Zhang B.,Li X.,Xu W.,Xing F.. 2024

[17]Synergistic risk in the gut and liver: Insights into the toxic mechanisms and molecular interactions of combined exposure to triazophos and fenvalerate in zebrafish. Xuehua An,Ruike Wang,Chong Cao,Dou Wang,Chen Chen,Yanhua Wang. 2024

[18]Decoding the role of the intestinal epithelium in hepatitis E virus infection using a human organoid prototype of “gut-liver” axis. Kuan Liu,Yang Wang,Jiangrong Zhou,Joy Joàn van der Meij,Luc J.W. van der Laan,Pengfei Li,Qiuwei Pan. 2025

[19]Heat-Inactivated Lactiplantibacillus plantarum FRT4 Alleviates Diet-Induced Obesity via Gut-Liver Axis Reprogramming. Huang, Yuyin,Wang, Qingya,Han, Xiling,Meng, Kun,Liu, Guohua,Zhang, Haiou,Zhang, Rui,Cai, Hongying,Yang, Peilong. 2025

[20]Influence of different dietary levels of zinc on performance, vitamin B-12, and blood parameters in lambs. Wang, Runlian,Zhu, Xiaoping,Guo, Fucun,Zhang, Wei,Jia, Zhihai. 2006

作者其他论文 更多>>